This characteristic may be particularly advantageous for treating inflammatory bone diseases, such as rheumatoid arthritis, where NF-κB serves as the primary mediator of inflammatory cytokine-induced osteoclastogenesis. This evidence concerns the gene NFKB1 and rheumatoid arthritis.